PATHOBIOLOGY OF BETA CELL DYSFUNCTION AND APOPTOSIS IN DIABETES MELLITUS
PATHOBIOLOGY OF BETA CELL DYSFUNCTION AND APOPTOSIS IN DIABETES MELLITUS
批准号:
6239048
负责人:
KENNETH S POLONSKY
金额:
$22.49万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-09-30 至 1998-11-30
关键词:
NOD mouse apoptosis calcium channel calcium flux cellular pathology disease /disorder model gene expression glucokinase glucose metabolism glucose transport insulin insulin dependent diabetes mellitus laboratory rat molecular pathology pancreatic islet function potassium channel prediabetic state tissue /cell culture transfection voltage /patch clamp
中文摘要
这个项目的总体目标是确定分子缺陷
与糖尿病中β细胞功能障碍相关的研究,
分子生物学结合整体器官和细胞生理学。
将用离体灌注胰腺进行研究,以确定
使用药理学试剂调节振荡胰岛素分泌
其影响胰岛素分泌途径中的特定位点,
ATP敏感性K+通道和L型Ca 2+通道。 结果将
与氨基酸诱导的胰岛素分泌相比。 的改变
分泌振荡和它们对这些促分泌素的反应将是
在患有糖尿病的动物的胰腺中测定,糖尿病是由于自身免疫性疾病
β细胞破坏(DP BB/Wor大鼠)或β细胞群减少(GK
大鼠)和输注大量葡萄糖以诱导β细胞的动物
功能障碍 这些实验将使我们能够验证这样一个假设,
β细胞功能障碍的状态与低幅度有关,
不规则分泌振荡 此外,我们建议研究
编码葡糖激酶的基因表达的改变,和
这两种蛋白质在调节细胞内Ca 2+中起关键作用
信令,即,电压依赖性钙通道和IP 3受体。
将结果与GLUT 2表达的改变进行比较。
基因 这些研究将使我们能够验证糖尿病
导致GLUT 2、葡萄糖激酶或ATP敏感性K+
相对保留电压依赖性Ca 2+通道和IP 3通道
受体的 最后,将进行实验以确定
正常胰岛中存在的振荡胰岛素分泌模式持续存在
在从糖尿病大鼠分离的胰岛、分散的胰岛和胰岛素中,
分泌细胞系。 一种模型β细胞系,β TC 3细胞系具有
已被证明可以增加其对胰岛素的反应性,
当与高葡萄糖相比时,在低葡萄糖中孵育。 分子
下面将研究高葡萄糖这种效应的潜在机制
将这些细胞在高和低葡萄糖中孵育。 电压的作用
依赖性Ca ~(2+)和K ~+通道及IP 3受体在调节
将通过检测正常人的胰岛素分泌来研究该细胞系中的胰岛素分泌。
以及这些基因的突变形式,并表征对胰岛素的影响,
分泌量 这些研究将增加我们对正常
β细胞生理学和病理生理学,并将促进
开发新的药理学和其他治疗方法,
最大限度地保护和维持β细胞功能,
早期胰岛素依赖型糖尿病患者和胰岛细胞移植受者。
英文摘要
The overall goal of this project is to define the molecular defects
associated with the beta cell dysfunction in diabetes using techniques of
molecular biology combined with whole organ and cellular physiology.
Studies will be conducted with the isolated perfused pancreas to define the
regulation of oscillatory insulin secretion using pharmacologic agents
which affect specific sites in the insulin secretory pathway including the
ATP-sensitive K+ channel and the L-type Ca2+ channel. The results will be
compared with amino acid induced insulin secretion. Alterations in the
secretory oscillations and their response to these secretagogues will be
determined in pancreata from animals with diabetes due either to autoimmune
beta cell destruction (DP BB/Wor rat) or reduced beta cell mass (the GK
rat) and animals infused with large amounts of glucose to induce beta cell
dysfunction. These experiments will enable us to test the hypothesis that
states of beta cell dysfunction are associated with low amplitude,
irregular secretory oscillations. In addition we propose to examine
alterations in expression of the genes which encode for glucokinase, and
two proteins which play a key role in the regulation of intracellular Ca2+
signalling, i.e., the voltage dependent Ca2+-channel and the IP3 receptor.
The results will be compared with alterations in expression of the GLUT2
gene. These studies will allow us to test the hypothesis that diabetes
causes abnormalities in either GLUT2, glucokinase or the ATP-sensitive K+
channel with relative sparing of the voltage dependent Ca2+ channel and IP3
receptor. Finally, experiments will be performed to determine if the
pattern of oscillatory insulin secretion present in normal islets persists
in islets isolated from diabetic rats, dispersed islets and in insulin
secreting cell lines. A model beta cell line, the betaTC3 cell line has
been demonstrated to increase its responsiveness to insulin after
incubation in low glucose when compared to high glucose. The molecular
mechanisms underlying this effect of high glucose will be studied following
incubation of these cells in high and low glucose. The role of voltage
dependent Ca2+ and K+ channels and the IP3 receptor in the regulation of
insulin secretion in this cell line will be studied by transfecting normal
and mutant forms of these genes and characterizing the effects on insulin
secretory output. These studies will increase our understanding of normal
beta cell physiology and pathophysiology in IDDM and will facilitate the
development of novel pharmacologic and other therapeutic approaches to
maximize our ability to preserve and maintain beta cell function in
patients with early IDDM and in islet cell transplant recipients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:8173740
-
项目类别:
-
资助金额:$33.75万
-
财政年份:2010
-
负责人:KENNETH S POLONSKY
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:8173736
-
项目类别:
-
资助金额:$33.75万
-
财政年份:2010
-
负责人:KENNETH S POLONSKY
-
依托单位:
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
-
批准号:8173738
-
项目类别:
-
资助金额:$185.61万
-
财政年份:2010
-
负责人:KENNETH S POLONSKY
-
依托单位:
WASHINGTON UNIVERSITY INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCES
-
批准号:8173739
-
项目类别:
-
资助金额:$421.83万
-
财政年份:2010
-
负责人:KENNETH S POLONSKY
-
依托单位:
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
-
批准号:8173737
-
项目类别:
-
资助金额:$168.73万
-
财政年份:2010
-
负责人:KENNETH S POLONSKY
-
依托单位:
A PROOF-OF-CONCEPT CLINICAL TRIAL OF XENIN-25 IN THE TREATMENT OF TYPE 2 DIABETES
-
批准号:7814484
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2009
-
负责人:KENNETH S POLONSKY
-
依托单位:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
-
批准号:7719816
-
项目类别:
-
资助金额:$19.36万
-
财政年份:2008
-
负责人:KENNETH S POLONSKY
-
依托单位:
WASHINGTON UNIVERSITY INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCES
-
批准号:7719819
-
项目类别:
-
资助金额:$562.16万
-
财政年份:2008
-
负责人:KENNETH S POLONSKY
-
依托单位:
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
-
批准号:7719817
-
项目类别:
-
资助金额:$73.32万
-
财政年份:2008
-
负责人:KENNETH S POLONSKY
-
依托单位:
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
-
批准号:7719818
-
项目类别:
-
资助金额:$162.94万
-
财政年份:2008
-
负责人:KENNETH S POLONSKY
-
依托单位:
WASHINGTON UNIVERSITY INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCES
-
批准号:7562972
-
项目类别:
-
资助金额:$272.76万
-
财政年份:2007
-
负责人:KENNETH S POLONSKY
-
依托单位:
ISLET TRANSPLANTATION IN TYPE 1 DIABETIC PATIENTS USING THE EDMONTON PROTOCOL
-
批准号:7603308
-
项目类别:
-
资助金额:$0.11万
-
财政年份:2007
-
负责人:KENNETH S POLONSKY
-
依托单位:
Washington University Institute of Clinical and Translational Sciences (KL2)
-
批准号:7497167
-
项目类别:
-
资助金额:$168.36万
-
财政年份:2007
-
负责人:KENNETH S POLONSKY
-
依托单位:
WASHINGTON UNIVERSITY INSTITUTE CTSA FOR AIDS RESEARCH
-
批准号:7562969
-
项目类别:
-
资助金额:$68.19万
-
财政年份:2007
-
负责人:KENNETH S POLONSKY
-
依托单位:
REGULATION OF HEPATIC INSULIN EXTRACTION
-
批准号:7603307
-
项目类别:
-
资助金额:$0.94万
-
财政年份:2007
-
负责人:KENNETH S POLONSKY
-
依托单位:
Washington University Institute of Clinical and Translational Sciences (TL1)
-
批准号:7489753
-
项目类别:
-
资助金额:$34.87万
-
财政年份:2007
-
负责人:KENNETH S POLONSKY
-
依托单位:
WASHINGTON UNIVERSITY INSTITUTE CTSA FOR PEDIATRIC RESEARCH
-
批准号:7562970
-
项目类别:
-
资助金额:$68.19万
-
财政年份:2007
-
负责人:KENNETH S POLONSKY
-
依托单位:
Washington University Institute of Clinical and Translational Sciences (UL1)
-
批准号:7489730
-
项目类别:
-
资助金额:$681.89万
-
财政年份:2007
-
负责人:KENNETH S POLONSKY
-
依托单位:
Washington University Institute of Clinical and Translational Sciences (KL2)
-
批准号:7651423
-
项目类别:
-
资助金额:$172.84万
-
财政年份:2007
-
负责人:KENNETH S POLONSKY
-
依托单位:
ISLET FUNCTION & CLINICAL ANALYSES OF TRANSPLANT RECIPIENTS
-
批准号:7603310
-
项目类别:
-
资助金额:$0.04万
-
财政年份:2007
-
负责人:KENNETH S POLONSKY
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: